150 related articles for article (PubMed ID: 37760550)
1. Machine Learning for Digital Scoring of PRMT6 in Immunohistochemical Labeled Lung Cancer.
Mahmoud AM; Brister E; David O; Valyi-Nagy K; Sverdlov M; Gann PH; Kim SJ
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760550
[TBL] [Abstract][Full Text] [Related]
2. Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer.
Pan B; Kang Y; Jin Y; Yang L; Zheng Y; Cui L; Sun J; Feng J; Li Y; Guo L; Liang Z
J Transl Med; 2021 Jun; 19(1):249. PubMed ID: 34098964
[TBL] [Abstract][Full Text] [Related]
3. A new AI-assisted scoring system for PD-L1 expression in NSCLC.
Huang Z; Chen L; Lv L; Fu CC; Jin Y; Zheng Q; Wang B; Ye Q; Fang Q; Li Y
Comput Methods Programs Biomed; 2022 Jun; 221():106829. PubMed ID: 35660765
[TBL] [Abstract][Full Text] [Related]
4. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer.
Hondelink LM; Hüyük M; Postmus PE; Smit VTHBM; Blom S; von der Thüsen JH; Cohen D
Histopathology; 2022 Mar; 80(4):635-647. PubMed ID: 34786761
[TBL] [Abstract][Full Text] [Related]
6. PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.
Tang J; Meng Q; Shi R; Xu Y
Mol Med Rep; 2020 Oct; 22(4):3161-3172. PubMed ID: 32945431
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Semi-Quantitative Scoring and Artificial Intelligence Aided Digital Image Analysis of Chromogenic Immunohistochemistry.
Bencze J; Szarka M; Kóti B; Seo W; Hortobágyi TG; Bencs V; Módis LV; Hortobágyi T
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053167
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence for tumour tissue detection and histological regression grading in oesophageal adenocarcinomas: a retrospective algorithm development and validation study.
Tolkach Y; Wolgast LM; Damanakis A; Pryalukhin A; Schallenberg S; Hulla W; Eich ML; Schroeder W; Mukhopadhyay A; Fuchs M; Klein S; Bruns C; Büttner R; Gebauer F; Schömig-Markiefka B; Quaas A
Lancet Digit Health; 2023 May; 5(5):e265-e275. PubMed ID: 37100542
[TBL] [Abstract][Full Text] [Related]
9. A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer.
Taylor CR; Jadhav AP; Gholap A; Kamble G; Huang J; Gown A; Doshi I; Rimm DL
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):263-269. PubMed ID: 30640753
[TBL] [Abstract][Full Text] [Related]
10. Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software.
Naso JR; Povshedna T; Wang G; Banyi N; MacAulay C; Ionescu DN; Zhou C
Pathol Oncol Res; 2021; 27():609717. PubMed ID: 34257575
[TBL] [Abstract][Full Text] [Related]
11. Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis.
Widmaier M; Wiestler T; Walker J; Barker C; Scott ML; Sekhavati F; Budco A; Schneider K; Segerer FJ; Steele K; Rebelatto MC
Mod Pathol; 2020 Mar; 33(3):380-390. PubMed ID: 31527709
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer.
Jasani B; Bänfer G; Fish R; Waelput W; Sucaet Y; Barker C; Whiteley JL; Walker J; Hovelinck R; Diezko R
Diagn Pathol; 2020 Apr; 15(1):37. PubMed ID: 32303234
[TBL] [Abstract][Full Text] [Related]
13. Bridging the gap between prostate radiology and pathology through machine learning.
Bhattacharya I; Lim DS; Aung HL; Liu X; Seetharaman A; Kunder CA; Shao W; Soerensen SJC; Fan RE; Ghanouni P; To'o KJ; Brooks JD; Sonn GA; Rusu M
Med Phys; 2022 Aug; 49(8):5160-5181. PubMed ID: 35633505
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer.
Wu J; Liu C; Liu X; Sun W; Li L; Gao N; Zhang Y; Yang X; Zhang J; Wang H; Liu X; Huang X; Zhang Y; Cheng R; Chi K; Mao L; Zhou L; Lin D; Ling S
Mod Pathol; 2022 Mar; 35(3):403-411. PubMed ID: 34518630
[TBL] [Abstract][Full Text] [Related]
15. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer.
Rimm DL; Han G; Taube JM; Yi ES; Bridge JA; Flieder DB; Homer R; West WW; Wu H; Roden AC; Fujimoto J; Yu H; Anders R; Kowalewski A; Rivard C; Rehman J; Batenchuk C; Burns V; Hirsch FR; Wistuba II
JAMA Oncol; 2017 Aug; 3(8):1051-1058. PubMed ID: 28278348
[TBL] [Abstract][Full Text] [Related]
16. PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosis.
Jiang N; Li QL; Pan W; Li J; Zhang MF; Cao T; Su SG; Shen H
Int J Biochem Cell Biol; 2020 Mar; 120():105681. PubMed ID: 31884111
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.
Dowhan DH; Harrison MJ; Eriksson NA; Bailey P; Pearen MA; Fuller PJ; Funder JW; Simpson ER; Leedman PJ; Tilley WD; Brown MA; Clarke CL; Muscat GE
Endocr Relat Cancer; 2012 Aug; 19(4):509-26. PubMed ID: 22673335
[TBL] [Abstract][Full Text] [Related]
18. Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies.
Kapil A; Meier A; Zuraw A; Steele KE; Rebelatto MC; Schmidt G; Brieu N
Sci Rep; 2018 Nov; 8(1):17343. PubMed ID: 30478349
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of protein arginine methyltransferase 6 expression in colon cancer.
Lim Y; Yu S; Yun JA; Do IG; Cho L; Kim YH; Kim HC
Oncotarget; 2018 Feb; 9(10):9010-9020. PubMed ID: 29507670
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression.
Okuno K; Akiyama Y; Shimada S; Nakagawa M; Tanioka T; Inokuchi M; Yamaoka S; Kojima K; Tanaka S
Carcinogenesis; 2019 Mar; 40(1):15-26. PubMed ID: 30508037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
